American Vanguard AVD Diflubenzuron And PCNB Intangible Assets — Asset Impairment Charges
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by American Vanguard in its filing.
Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.
The official record: American Vanguard’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →
Ask your AI about American Vanguard's diflubenzuron and pcnb intangible assets — asset impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is American Vanguard's diflubenzuron and PCNB intangible assets — asset impairment charges?
- American Vanguard (AVD) reported diflubenzuron and PCNB intangible assets — asset impairment charges of $450.5K in Q4 2025.
- What does diflubenzuron and PCNB intangible assets — asset impairment charges mean?
- This metric represents the non-cash expense recognized when the carrying value of intangible assets associated with specific chemical product lines exceeds their fair market value. It serves as an indicator of diminished economic potential or reduced future cash flow expectations for these specialized agricultural and pest control assets. Monitoring these charges helps investors assess the recoverability of investments in specific product portfolios and the potential for future write-downs.